摘要
专利制度属于民事法律范畴,中药品种保护制度属于市场管理法范畴,两者对中药产品的保护各有侧重与利弊,效力各有强弱,在功能作用上可形成互补。为满足新时期中医药事业发展的要求,中药品种保护制度应立足中医药的传承与创新,扩大保护范围,完善审评模式,规范退出机制,以达到维护中药企业权益,提升中药产品整体质量的目的。
Patent legal system is a part of civil law, while protection system for the varieties of traditional Chinese medicines is involved in the market regulation law. Both of them emphasize on different aspects complementarily in protecting traditional Chinese medicine(TCM) with advantages and disadvantages. To meet the requirements of the development of TCM in the new era, protection scope of the protection system for varieties of traditional Chinese medicines should be promoted, examination system and elimination mechanisms should be improved through the inheritance and innovation of TCM, which may be conducive to protect rights and interests of TCM enterprises and improve the quality of varieties of traditional Chinese medicines.
出处
《世界科学技术-中医药现代化》
CSCD
2017年第2期223-227,共5页
Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金
2016年度国家社科基金委重大项目(16ZDA236):中医药传统知识保护专门制度研究
负责人:宋晓亭
关键词
专利制度
中药品种保护制度
比较
Patent legal system
protection system for varieties of traditional Chinese medicines
comparison